Literature DB >> 30108054

Overdiagnosis in primary care: framing the problem and finding solutions.

Minal S Kale1, Deborah Korenstein2.   

Abstract

Overdiagnosis, is defined as the diagnosis of a condition that, if unrecognized, would not cause symptoms or harm a patient during his or her lifetime, and it is increasingly acknowledged as a consequence of screening for cancer and other conditions. Because preventive care is a crucial component of primary care, which is delivered to the broad population, overdiagnosis in primary care is an important problem from a public health perspective and has far reaching implications. The scope of overdiagnosis as a result of services delivered in primary care is unclear, though overdiagnosis of indolent breast, prostate, thyroid, and lung cancers is well described and overdiagnosis of chronic kidney disease, depression, and attention-deficit/hyperactivity disorder is also recognized. However, overdiagnosis is a known consequence of all screening and can be assumed to occur in many more clinical contexts. Overdiagnosis can harm patients by leading to overtreatment (with associated potential toxicities), diagnosis related anxiety or depression, and labeling, or through financial burden. Many entrenched factors facilitate overdiagnosis, including the growing use of advanced diagnostic technology, financial incentives, a medical culture that encourages greater use of tests and treatments, limitations in the evidence that obscure the understanding of diagnostic utility, use of non-beneficial screening tests, and the broadening of disease definitions. Efforts to reduce overdiagnosis are hindered by physicians' and patients' lack of awareness of the problem and by confusion about terminology, with overdiagnosis often conflated with related concepts. Clarity of terminology would facilitate physicians' understanding of the problem and the growth in evidence regarding its prevalence and downstream consequences in primary care. It is hoped that international coordination regarding diagnostic standards for disease definitions will also help minimize overdiagnosis in the future. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2018        PMID: 30108054      PMCID: PMC6889862          DOI: 10.1136/bmj.k2820

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  109 in total

1.  Drugs for pre-osteoporosis: prevention or disease mongering?

Authors:  Pablo Alonso-Coello; Alberto López García-Franco; Gordon Guyatt; Ray Moynihan
Journal:  BMJ       Date:  2008-01-19

2.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

3.  Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice.

Authors:  S J Lord; L P Staub; P M M Bossuyt; L M Irwig
Journal:  BMJ       Date:  2011-09-07

Review 4.  Treatment of low-risk ductal carcinoma in situ: is nothing better than something?

Authors:  John R Benson; Ismail Jatoi; Masakazu Toi
Journal:  Lancet Oncol       Date:  2016-10       Impact factor: 41.316

5.  Experience of US Patients Who Self-identify as Having an Overdiagnosed Thyroid Cancer: A Qualitative Analysis.

Authors:  Louise Davies; Chase D Hendrickson; Gregory S Hanson
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-07-01       Impact factor: 6.223

6.  Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

Authors:  Salvatore Vaccarella; Silvia Franceschi; Freddie Bray; Christopher P Wild; Martyn Plummer; Luigino Dal Maso
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

7.  A definition and ethical evaluation of overdiagnosis.

Authors:  Stacy M Carter; Chris Degeling; Jenny Doust; Alexandra Barratt
Journal:  J Med Ethics       Date:  2016-07-08       Impact factor: 2.903

8.  Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013.

Authors:  J Bradley Layton; Yoonsang Kim; G Caleb Alexander; Sherry L Emery
Journal:  JAMA       Date:  2017-03-21       Impact factor: 56.272

9.  Guidance for Modifying the Definition of Diseases: A Checklist.

Authors:  Jenny Doust; Per O Vandvik; Amir Qaseem; Reem A Mustafa; Andrea R Horvath; Allen Frances; Lubna Al-Ansary; Patrick Bossuyt; Robyn L Ward; Ina Kopp; Laragh Gollogly; Holger Schunemann; Paul Glasziou
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

Review 10.  Patient and provider experiences with active surveillance: A scoping review.

Authors:  Claire Kim; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

View more
  26 in total

1.  The elusive diagnosis of cancer: testing times.

Authors:  Brian D Nicholson; Rafael Perera; Matthew J Thompson
Journal:  Br J Gen Pract       Date:  2018-11       Impact factor: 5.386

Review 2.  [The problem of medical overuse : Finding a definition and solutions].

Authors:  T Gamstätter
Journal:  Internist (Berl)       Date:  2021-02-13       Impact factor: 0.743

Review 3.  Higher order thinking about differential diagnosis.

Authors:  Chad E Cook; Simon Décary
Journal:  Braz J Phys Ther       Date:  2019-01-30       Impact factor: 3.377

Review 4.  Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Authors:  Nicole E Rich; Amit G Singal
Journal:  Hepatology       Date:  2022-01-18       Impact factor: 17.425

5.  Diagnosing chronic endometritis: when simplification fails to clarify.

Authors:  Maximilian Murtinger; Barbara Wirleitner; Dietmar Spitzer; Helena Bralo; Susanna Miglar; Maximilian Schuff
Journal:  Hum Reprod Open       Date:  2022-06-07

6.  The burden of gastric cancer.

Authors:  Chisato Hamashima
Journal:  Ann Transl Med       Date:  2020-06

Review 7.  Pregnant pause: should we screen for sleep disordered breathing in pregnancy?

Authors:  Alex Perkins; Alys Einion
Journal:  Breathe (Sheff)       Date:  2019-03

8.  The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.

Authors:  Rupert W Major; David Shepherd; James F Medcalf; Gang Xu; Laura J Gray; Nigel J Brunskill
Journal:  PLoS Med       Date:  2019-11-06       Impact factor: 11.069

9.  Is it really always only the others who are to blame? GP's view on medical overuse. A questionnaire study.

Authors:  Maximilian Pausch; Angela Schedlbauer; Maren Weiss; Thomas Kuehlein; Susann Hueber
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

10.  Cost-effectiveness of breast, lung, colon, prostate and cervical cancer outcomes in Brazil: a worldwide comparison.

Authors:  Rodrigo Pellegrini; Tomás Reinert; Carlos Henrique Barrios
Journal:  Ecancermedicalscience       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.